OSF Ventures
Profile and portfolio
OSF Ventures is the corporate venture arm of OSF HealthCare, a healthcare company. It was founded in 2016 and is based in Peoria, United States. It invests at the Series A stage. Sectors it names: healthcare and digital health, medical devices, biotech and life sciences.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Series A to Series A |
| Sectors | Healthcare and digital health, Medical devices, Biotech and life sciences |
| Geography | North America |
| Offices | Peoria, United States |
Sources: S1 OSF Ventures.
Data behind this graphic
| Item | Companies | Share |
|---|---|---|
| Active | 21 | 65.6% |
| Exited | 11 | 34.4% |
Status as the firm tags it
Sources: S2 OSF Ventures portfolio.
Where it invests and who leads it
LeadersS1
- Mayank TanejaVice President, Venture InvestmentsFind on LinkedInFirm page
- Liridon RrushajDirector, Venture InvestmentsFind on LinkedInFirm page
- Ben SpektorDirector, Venture InvestmentsFind on LinkedInFirm page
- Danielle KalinskyManager of Venture InvestmentsFind on LinkedInFirm page
- Jeremy SnellVenture AnalystFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | OSF HealthCare | Single source | S1 |
| Parent industry | Healthcare and life sciences | Single source | S1 |
| Founded | 2016 | Single source | S3 |
| Headquarters | Peoria, United States | Single source | S3 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S1 |
| Companies backed | 32+ | Single source | S2 |
| Exits | 11 total | Single source | S2 |
| Stages | Series A (inferred from announced rounds) | Estimate | S1 |
Notable outcomes
IPOs and acquisitions of portfolio companies. Price shown only where published.
| Company | Type | Year | Acquirer or exchange | Source |
|---|---|---|---|---|
| CareSignal | Acquisition | 2021 | Lightbeam Health Solutions | S2 |
| Current Health | Acquisition | 2021 | Best Buy | S2 |
| Gauss | Acquisition | 2021 | Stryker | S2 |
| Health Catalyst | IPO | 2019 | S2 | |
| Level Ex | Acquisition | 2020 | Brainlabs | S2 |
| PatientWisdom | Acquisition | 2021 | NRC | S2 |
| Respiratory Motion | Acquisition | 2022 | Senzime | S2 |
| BrightWater Medical | Acquisition | 2019 | Merit Medical Systems | S2 |
| Paradigm Diagnostics | Acquisition | 2020 | Exact Sciences | S2 |
| SilverCloud Health | Acquisition | 2021 | Amwell | S2 |
| Gyant | Acquisition | 2024 | Fabric | S2 |
Portfolio
The firm's portfolio page lists 32 companies: 21 active, 11 exited.S2
| Tag | Companies | Share |
|---|---|---|
| Active | 21 | 65.6% |
| Exited | 11 | 34.4% |
Every company on the OSF Ventures list
32 companies, as listed on the firm's own website: 21 active, 11 exited.S2 Read the firm's list.
Active 21
- 410 Medical
- Array Behavioral Care
- AVIA
- Cala Health
- CancerIQ
- Cardiosense
- Digital Diagnostics
- DotCom Therapy
- Endotronix
- Epitel
- Euphrates Vascular
- Exo Imaging
- Hellocare
- Inflammatix
- InsightRX
- PhotoniCare
- Piecestech
- ShiraTronics
- Socially Determined
- TailorMed
- VIDA
Exited 11
- BrightWater Medical
- CareSignal
- Current Health
- Gauss
- Gyant
- Health Catalyst
- Level Ex
- Paradigm Diagnostics
- PatientWisdom
- Respiratory Motion
- SilverCloud Health
Official pages
Read the firm's own pages for current information.
- Website www.osfinnovation.org/invest/osf-ventures
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by OSF Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.